Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Aug 27, 2020
Date Accepted: Aug 23, 2021

The final, peer-reviewed published version of this preprint can be found here:

An mHealth-Based Intervention for Adolescents With Type 1 Diabetes and Their Parents: Pilot Feasibility and Efficacy Single-Arm Study

Holtz BE, Mitchell KM, Holmstrom AJ, Cotten SR, Dunneback JK, Jimenez Vega J, Ellis DA, Wood MA

An mHealth-Based Intervention for Adolescents With Type 1 Diabetes and Their Parents: Pilot Feasibility and Efficacy Single-Arm Study

JMIR Mhealth Uhealth 2021;9(9):e23916

DOI: 10.2196/23916

PMID: 34519670

PMCID: 8479605

An mHealth-Based Intervention, For Adolescents with Type 1 Diabetes and Their Parents: A Pilot Study

  • Bree E Holtz; 
  • Katharine M Mitchell; 
  • Amanda J Holmstrom; 
  • Shelia R Cotten; 
  • Julie K Dunneback; 
  • Jose Jimenez Vega; 
  • Deborah A Ellis; 
  • Michael A Wood

ABSTRACT

Background:

Type 1 diabetes (T1D) impacts more than 165,000 individuals under the age of 20 in the United States. The transition from parent management to parent-child team management, with the child taking on increased levels of self-care, can be stressful and is associated with a deterioration in self-management behaviors. A mobile app intervention, MyT1DHero was designed to facilitate diabetes-specific positive parent-adolescent communication.

Objective:

To conduct a pilot test to determine the efficacy of the MyT1DHero app intervention.

Methods:

This pilot study included 30 adolescent-parent pairs in a 12-week single arm clinical trial.

Results:

The final analysis included 25 families. The mean age of the adolescents was 12.281.62 years old. Half of the participants reported a diagnosis of fewer than five years. After 12-weeks, diabetes adherence significantly improved (P=.02) as did quality of life (P=0.01). HbA1c level (P=.51) and family conflict (P=0.14) changed in the hypothesized direction, but the change was not significant. However, higher use of the mobile app was associated with more improvement in HbA1c, (F(1, 20)=9.74, P<.01, R2=.33). Overall, the adolescents were satisfied with the app intervention.

Conclusions:

In a 12-week pilot study of the mobile app intervention designed to facilitate parent-adolescent communication, significant benefits were demonstrated in adherence and quality of life. A randomized controlled trial with a longer intervention is needed to replicate these findings and determine the stability of intervention effects. ClinicalTrials.gov Identifier: NCT03436628


 Citation

Please cite as:

Holtz BE, Mitchell KM, Holmstrom AJ, Cotten SR, Dunneback JK, Jimenez Vega J, Ellis DA, Wood MA

An mHealth-Based Intervention for Adolescents With Type 1 Diabetes and Their Parents: Pilot Feasibility and Efficacy Single-Arm Study

JMIR Mhealth Uhealth 2021;9(9):e23916

DOI: 10.2196/23916

PMID: 34519670

PMCID: 8479605

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.